Law360, New York ( March 27, 2015, 12:47 PM EDT) -- In a recently issued 8-K, Biomet Inc., an Indiana-based medical device company, announced that the U.S. Department of Justice had extended the company's deferred prosecution agreement and monitorship relating to violations of the Foreign Corrupt Practices Act.[1] While few details have been disclosed relating to this historic extension, its warning is clear — where prosecutors question a company's candor, cooperation or remediation of issues, the grip of formal oversight will not be easily released....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.